Creative Planning
AURA icon

Creative Planning’s Aura Biosciences AURA Stock Holding History

Creative Planning’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$94.1K Buy
14,073
+2,779
+25% +$15.9K ﹤0.01% 3917
2025
Q4 		$61.6K Buy
+11,294
New +$67.1K ﹤0.01% 3781
2025
Q2 		– Sell
-10,157
Closed -$59.5K – 3687
2025
Q1 		$59.5K Sell
10,157
-11,258
-53% -$85.2K ﹤0.01% 3326
2024
Q4 		$176K Buy
+21,415
New +$202K ﹤0.01% 3011

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Creative Planning's AURA Position: Q1 2026 in Review

Creative Planning increased its Aura Biosciences (AURA) stake by 25% in Q1 2026, buying an estimated $15.9K and bringing the position to 14,073 shares worth $94.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3917.

Creative Planning first reported a position in AURA in Q4 2024 and has held it in 4 quarters since. The position peaked at $176K in Q4 2024. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

  • Creative Planning held 14,073 shares of Aura Biosciences worth $94.1K as of Q1 2026.
  • Creative Planning bought 2,779 Aura Biosciences shares in Q1 2026, an estimated $15.9K.
  • Aura Biosciences made up ﹤0.01% of Creative Planning's portfolio in Q1 2026, its #3917 holding.
  • Creative Planning first reported a position in Aura Biosciences in Q4 2024 and has held it in 4 quarters since.
  • Creative Planning's Aura Biosciences position peaked at $176K in Q4 2024.
  • 126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.